+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Preclinical Drug"

Asia-Pacific Pharmaceutical Industry Outlook 2023 - Product Thumbnail Image

Asia-Pacific Pharmaceutical Industry Outlook 2023

  • Report
  • April 2023
  • 77 Pages
  • Asia Pacific
From
From
From
From
From
From
Global Contract Research Organization (CRO) Growth Opportunities - Product Thumbnail Image

Global Contract Research Organization (CRO) Growth Opportunities

  • Report
  • November 2022
  • 117 Pages
  • Global
From
Global Patient Derived Xenograft Market 2021-2025 - Product Thumbnail Image

Global Patient Derived Xenograft Market 2021-2025

  • Report
  • December 2021
  • 120 Pages
  • Global
From
  • 15 Results (Page 1 of 1)
Loading Indicator

The Preclinical Drug market is a segment of the Pharmaceuticals industry that focuses on the development of drugs prior to clinical trials. This includes the research and development of new drugs, as well as the testing of existing drugs for safety and efficacy. Preclinical Drug development involves a range of activities, such as the synthesis of new compounds, the evaluation of their pharmacological properties, and the assessment of their toxicity. The results of these activities are used to determine whether a drug is suitable for clinical trials. The Preclinical Drug market is highly competitive, with a number of companies offering a range of services. These include contract research organizations (CROs), drug discovery companies, and pharmaceutical companies. Examples of companies in the market include Charles River Laboratories, WuXi AppTec, and Parexel. Show Less Read more